Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

novartis corporation (malaysia) sdn. bhd. - enoxaparin sodium -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

novartis corporation (malaysia) sdn. bhd. - enoxaparin sodium -

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - insulin glulisine 3.49 mg/ml - solution for injection - 100 iu/ml - active: insulin glulisine 3.49 mg/ml excipient: cresol hydrochloric acid polysorbate 20 sodium chloride sodium hydroxide trometamol water for injection - apidra is indicated for the treatment of type 1 and type 2 diabetes mellitus in adults and children of 4 years or above who require insulin for the control of hyperglycaemia.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - insulin glulisine 3.49 mg/ml - solution for injection - 100 iu/ml - active: insulin glulisine 3.49 mg/ml excipient: hydrochloric acid metacresol polysorbate 20 sodium chloride sodium hydroxide trometamol water for injection - apidra is indicated for the treatment of type 1 and type 2 diabetes mellitus in adults and children of 4 years or above who require insulin for the control of hyperglycaemia.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - insulin glargine 100 iu/ml equivalent to 3.6378 mg/ml - solution for injection - 100 iu/ml - active: insulin glargine 100 iu/ml equivalent to 3.6378 mg/ml excipient: glycerol hydrochloric acid metacresol polysorbate 20 sodium hydroxide water for injection zinc chloride - lantus is an insulin analogue indicated for once-daily subcutaneous administration in the treatment of type 1 or type 2 diabetes mellitus patients who require insulin for the control of hyperglycaemia.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - insulin glargine 3.6378 mg/ml (100 iu/ml) - solution for injection - 100 iu/ml - active: insulin glargine 3.6378 mg/ml (100 iu/ml) excipient: glycerol hydrochloric acid metacresol sodium hydroxide water for injection zinc chloride - lantus is an insulin analogue indicated for once-daily subcutaneous administration in the treatment of type 1 or type 2 diabetes mellitus patients who require insulin for the control of hyperglycaemia.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - insulin glargine 100 iu/ml equivalent to 3.6378mg/ml - solution for injection - 100 iu/ml - active: insulin glargine 100 iu/ml equivalent to 3.6378mg/ml excipient: glycerol hydrochloric acid metacresol polysorbate 20 sodium hydroxide water for injection zinc chloride - optisulin/optisulin solostar is an insulin analogue indicated for once-daily subcutaneous administration in the treatment of type 1 or type 2 diabetes mellitus patients who require insulin for the control of hyperglycaemia.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - insulin glargine 100 iu/ml equivalent to 3.6378mg/ml - solution for injection - 100 iu/ml - active: insulin glargine 100 iu/ml equivalent to 3.6378mg/ml excipient: glycerol hydrochloric acid metacresol sodium hydroxide water for injection zinc chloride - optisulin/optisulin solostar is an insulin analogue indicated for once-daily subcutaneous administration in the treatment of type 1 or type 2 diabetes mellitus patients who require insulin for the control of hyperglycaemia.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - choriogonadotropin alfa 250ug; choriogonadotropin alfa 250ug - solution for injection - 250 mcg/0.5ml - active: choriogonadotropin alfa 250ug excipient: mannitol methionine phosphoric acid poloxamer sodium hydroxide water for injection active: choriogonadotropin alfa 250ug excipient: dibasic sodium phosphate dihydrate mannitol methionine phosphoric acid poloxamer sodium hydroxide sodium phosphate water for injection - anovulatory or oligo-ovulatory women: ovidrel is administered to trigger ovulation and luteinisation in anovulatory or oligo-ovulatory patients after stimulation of follicular growth.

Israel - English - Ministry of Health

padagis israel agencies ltd, israel - immunoglobulins, normal human - solution for infusion - immunoglobulins, normal human 0.1 g/ml - immunoglobulins, normal human, for intravascular adm. - immunoglobulins, normal human, for intravascular adm. - gamunex is indicated as replacement therapy of primary immunodeficiency (pi) states in which severe impaiment of antibody forming capacity has been shown, such as congential agammaglobulinemia, common variable immunodeficiency, x-limked immunodeficiency with hyper igm, wiskott- aldrich syndrom, and severed combined immunodeficiencies. gamunex is also indicated in idiopathic thrombocytopenia purpura (itp) to raise platelet counts to prevent bleeding or to allow a patient with itp to undergo surgery.treatment of chronic inflammatory demyelinating polyneuropathy (cidp).